The North America hysteroscopy procedures market is expected to grow from USD 5.15 billion in 2025 to USD 8.07 billion by 2035, at a CAGR of 4.60%, driven by advances in minimally invasive techniques, increasing awareness, and rising demand for women's healthcare.

North America Hysteroscopy Procedures Market Statical Scope

The market is expected to grow due to growing infertility issues in the region, growing demand for minimally invasive procedures, and growing advancements in imaging technology as well.

The North America hysteroscopy procedures market is also observed to grow due to growing patient preference for outpatient facilities as well as higher usage of advanced hysteroscopy devices. Prevalence of different types of gynecological issues, such as uterine fibroids, abnormal uterine bleeding, and endometrial cancer, also helps to propel the growth of the market. Multiple benefits of the advanced procedure form, such as lower recovery time, lower pain, and reduced hospital stays, also help to fuel the growth of the market. Technological advancements in the form of better surgical instruments, robotic-assisted procedures, and enhanced precision also help to elevate the market's demand.

North America Hysteroscopy Procedures Market Share, By Procedure, 2025 (%)

• Diagnostic Hysteroscopy- The segment dominated the global market with 28% of the market share in 2025 and is majorly driven by higher demand for minimally invasive surgeries to detect various gynecological issues, such as abnormal bleeding, uterine fibroids, and other such issues.
• Polypectomy/Targeted Biopsy- The segment holds 18% of the market share and is majorly driven by issues such as endometrial polyps, leading to higher demand for its removal procedures and precise tissue sampling.
• IUD/Foreign Body Removal- The segment accounts for 12% of the market share and is driven by higher demand for precise and minimally invasive removal procedures and accurate localization.
• Tubal Cannulation/Recanalization- The segment has 8% of the market share and is majorly driven by patients requiring infertility treatment and fallopian tube obstruction management.

North America Hysteroscopy Procedures Market Share, By End Use, 2025 (%)

• Hospitals- The segment dominated the global market with 56% of the market share in 2025. The segment is observed to grow due to factors such as higher patient volume, availability of advanced gynecological infrastructure, and availability of healthcare professionals to perform complex hysteroscopy procedures.
• Clinics- The segment has a significant share of 26% and is driven by higher demand for outpatient care settings and minimally invasive procedures, which are helpful for faster recovery.
• Ambulatory Surgery Centers- The segment accounts for 18% of the market share and is driven by factors such as higher demand for minimally invasive procedures, faster recovery, and same-day release.

Competitive Landscape

• Hologic Inc.- The American company is primarily focused on improving women's health by early detection, diagnosis, and treatment. The company is also known for its Omni hysteroscope and Fluent fluid management.
• Olympus Corporation- The global leader in medical technology, specializing in endoscopes, therapeutic devices, and surgical solutions. The company also provides high-definition hysteroscopes.
• Stryker Corporation- The global leader of medical technologies provides innovative products in MedSurg, Neurotechnology, and Orthopedics for enhanced healthcare.
• Medtronic plc- One of the world's largest medical device companies, manufactures healthcare technologies for more than 70 complex healthcare issues.

Recent Developments in the Market

In March 2025, Olympus Corp. announced the launch of its first AI-powered clinical decision tool in a strategic partnership with a well-renowned firm, Ziosoft.

Segments Covered in the Report

By Procedure

• Diagnostic Hysteroscopy
• Polypectomy / Targeted Biopsy
• IUD / Foreign Body Removal
• Tubal Cannulation / Recanalization
• Myomectomy
• Endometrial Ablation
• Other

By End Use

• Hospitals
• Clinics
• Ambulatory Surgery Centers